NEW YORK, Jan. 8, 2019 /PRNewswire-PRWeb/ -- Cecelia Health, a leading diabetes management technology- enabled personalized
The focus of the study is to demonstrate scaled initiation, persistency and data-driven guidance for patients using a continuous glucose monitor (CGM) device such as the Dexcom G6 or the Abbott Freestyle Libre. Data from the T1D Exchange (T1DX) registry shows that those who use a CGM have a lower A1C and decrease their risk for severe HYPO and DKA events by almost 40%. (1)
"The health care industry today is failing when it comes to supporting people who use insulin to manage their glucose levels. People need access to the best technology available, and hands- down that is Continuous Glucose Monitoring (CGM)" said David Panzirer, Trustee of the Helmsley Charitable Trust, and a parent of two children with Type 1 diabetes. "Imagine the model evolving to include prescribing a CGM, onboarding, data interpretation, remote data monitoring, and eventually even adjusting insulin doses that can be titrated via a decision- support algorithm optimized for each individual by a Certified Diabetes Educator (CDE), under physician orders. This is how we all see the future and this pilot is the first step towards getting there."
"Diabetes is a job no one wants", said David Weingard CEO of Cecelia Health, "Our national team of CDE clinicians scale their reach through the use of our proprietary innovative technology to deliver effective and personalized one-on-one care. It is the personal and expert touch of a CDE that educates, supports and guides people to self-manage their diabetes while also empowering them to take advantage of all available resources so they can succeed in every way possible."
"We're excited to work on this innovative project that will measure and publish results related to improved glycemic control for patients using a CGM", said Dr. Roy Beck, Executive Director of the Jaeb Center for Health Research Foundation, "Our objective is to determine whether CGM can be effectively initiated by adults using insulin with online and remote training instead of clinic- based training and the impact on glycemic control. This initiative has the potential to provide tremendous innovation through proven models within the diabetes landscape."
(1) "Funding the Future of Diabetes Care: It gets Personal", https://tcoyd.org/2018/10/funding-the-future-of-diabetes- care-it-gets-personal/
About Cecelia Health
Cecelia Health is on a moonshot mission to transform the lives of people living with diabetes by providing scalable and effective diabetes management programs through an optimized mix of Certified Diabetes Educators (CDEs) and innovative technology to deliver measurable outcomes in an affordable manner. The Cecelia Health clinical team includes CDEs with clinical credentials as nurses, registered dietitians, pharmacists, exercise physiologists, social workers and more, who are all passionate about empowering people with diabetes to live rich, healthy and fulfilling lives. For more information please visit https://www.ceceliahealth.com.
About the Helmsley Charitable Trust
The Leona M. and Harry B. Helmsley Charitable Trust aspires to improve lives by supporting exceptional efforts in the U.S. and around the world in health and select place-based initiatives. Since beginning active grantmaking in 2008, Helmsley has committed more than $2 billion for a wide range of charitable purposes. For more information, visit http://www.helmsleytrust.org.
About the Jaeb Center for Health Research
The Jaeb Center for Health Research is a nonprofit research center in Tampa, Florida. Founded in 1993, the Center's mission is to expand scientific knowledge and improve public health by designing and conducting world-class clinical trials and epidemiologic research. The Center's research primarily focuses on eye diseases and diabetes, with most of its funding coming from the National Institutes of Health and several foundations. For more information, visit http://www.jaeb.org.
SOURCE Cecelia Health Partners
Subscribe to our Free Newsletters!